MedPath
NMPA Approval

Palonosetron Hydrochloride Injection

国药准字H20244107

June 25, 2024

Drug Information

盐酸帕洛诺司琼注射液

注射剂

5ml: 0.25mg(按C₁₉H₂₄N₂O计)

化学药品

June 25, 2024

Company Information

Applicant Company

贵州省贵阳市乌当区东风镇马百路云锦段1号

Manufacturing Company

山西省怀仁市高新技术工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸帕洛诺司琼注射液 - NMPA 批准文号 | MedPath